Filter
377
Filtered Results: 377
Text search:
Morris,
J.
Featured
Recommendations
37
New Publications
51
Language
Document type
No document type
169
Studies & Reports
95
Guidelines
74
Manuals
16
Fact sheets
12
Strategic & Response Plan
7
Situation Updates
3
Training Material
1
Countries / Regions
Russia
18
Western and Central Europe
14
Latin America and the Carribbean
13
Brazil
11
Global
10
India
9
Kenya
8
Eastern Europe
7
Ukraine
6
Mozambique
6
Uganda
6
Germany
5
Middle East and North Africa
5
Eastern Europe and Central Asia
5
Liberia
5
Rwanda
4
Africa
4
Venezuela
4
Nepal
3
Colombia
3
Mexico
3
Syria
3
Kyrgyzstan
3
West and Central Africa
3
Jamaica
3
Spain
3
Bangladesh
3
South Africa
3
Yemen
3
Indonesia
3
Ghana
2
Cameroon
2
Zimbabwe
2
Asia
2
South–East Asia Region
2
Portugal
2
Bosnia and Herzegovina
2
East and Southern Africa
2
Argentina
2
Vietnam
2
Sudan
2
Ethiopia
2
South Sudan
2
Myanmar / Burma
2
North Macedonia
1
Tajikistan
1
Thailand
1
Lesotho
1
Sierra Leone
1
China
1
Kazakhstan
1
Nigeria
1
Senegal
1
Estonia
1
Burkina Faso
1
Afghanistan
1
Malawi
1
Morocco
1
USA
1
Haiti
1
Cambodia
1
Hungary
1
Congo, Democratic Republic of
1
Paraguay
1
North America
1
Turkmenistan
1
France
1
United Kingdom
1
Norway
1
Israel
1
Lebanon
1
Moldova
1
Sri Lanka
1
Egypt
1
Georgia
1
Botswana
1
Zambia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
111
Clinical Guidelines
44
Public Health
27
Women & Child Health
24
Key Resources
11
Pharmacy & Technologies
2
Capacity Building
1
Toolboxes
COVID-19
82
Mental Health
66
HIV
19
Planetary Health
19
NCDs
16
Disability
14
TB
12
Caregiver
10
AMR
9
Rapid Response
8
Refugee
7
Ebola
5
NTDs
5
Cholera
4
Pharmacy
3
Global Health Education
3
Zika
2
Natural Hazards
1
Social Ethics
1
Conflict
1
19 February 2021
The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also es...
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
28 Jan. 2021. L’objet de ce document est de fournir des orientations provisoires sur la sécurité biologique en laboratoire applicable à l’analyse d’échantillons cliniques issus de patients.
It estimates that there have been 228,000 additional deaths of children under five in these six countries [Afghanistan, Nepal, Bangladesh, India, Pakistan and Sri Lanka] due to crucial services, ranging from nutrition benefits to immunisation, being halted.
It says the number of children being tr...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
Orientations provisoires, 28 janvier 2021
Dans cette version mise à jour des orientations sur la sécurité biologique en laboratoire en rapport avec le SARS-CoV-2, le virus responsable de la maladie à coronavirus 2019 (COVID-19), les points suivants ont été ajoutés : aspects de...
COVID-19 is a pandemic that is currently ravaging the world. Infection rate is steadily increasingin Sub-Saharan Africa. Pregnant women and their infants may suffer severe illnesses due to theirlower immunity. This guideline prepares and equips clinicians working in the maternal and new-born section...
COVID-19 infection affects all age groups including newborns, however, literature is scarce on the fetal and neonatal outcomes of babies exposed in-utero, especially in Africa. The objectiveof this study was to document the perinatal outcomes of COVID-19 pregnancies and del...
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC), Global Research Collaboration for Infectious Dis...
This brief summarizes current evidence and guidance for maintaining safe and effective care across the spectrum of maternal, newborn and infant care while protecting mother and child and health care providers during COVID-19. Furthermore, implications of the principle of “do no harm” are reviewe...
The paper provides the rationale for these recommendations, which are based on analyses of data from the TRACT trial.
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass...
Las Infecciones Asociadas a la Atención en Salud (IAAS) son reconocidas en la
actualidad como un problema de salud pública y existen lineamientos guber-
namentales en la mayoría de los países para constituir sistemas de vigilancia y
Programas de Prevención y Control de Infecciones para con...
Because of the limited access to more powerful diagnostic tools, there is a paucity of data regarding the burden of fungal infections in Burkina Faso. The aim of this study was to estimate the incidence and prevalence of serious fungal infections in this sub-Saharan country. We primarily used the na...
11 august 2022, updated version
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how fiv...
